COVID-19 Vaccines

Getting to Yes, Michigan! (G2YMI)

A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much Money People Spend on Healthcare for COVID-19

The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01)

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

COVID-19 Serologies Among Healthcare Workers at CHSD (SERO2)

Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool

Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases

Impact of Maternal COVID-19 Vaccines on Breast Milk

PREPARE-iVAC Trial

Effect of a Third COVID-19 Booster Among Health Care Workers

INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old

UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects

UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)

Effectiveness of Vaccination Against COVID-19 in Brazil: Case-Control Study

The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate

Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals

Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in China

Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults